Financials
- Market Capitalization 5.8 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-151.06
市销率
7.09
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1231 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 105.61 USD | -0.22% | -5.90% | -0.03% | +351.52% | 5.91 B USD | ||
| 1237 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.22 USD | +0.38% | -1.29% | -4.73% | +47.63% | 5.83 B USD | ||
| 1259 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.10 USD | +1.29% | -0.04% | -1.06% | +51.83% | 5.66 B USD | ||
| 1278 | CRSP CRISPR Therapeutics AG - Common Shares | 56.98 USD | -1.28% | -1.64% | +18.61% | +11.73% | 5.51 B USD |